Cardiovascular Research Advance Access [Accepted Manuscript] published online on July 3, 2009
Cardiovascular Research, doi:10.1093/cvr/cvp225
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein Degradation Systems in Viral Myocarditis Leading to Dilated Cardiomyopathy
The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Providence Heart+Lung Institute, Department of Pathology and Laboratory Medicine, St. Paul's Hospital-University of British Columbia, Vancouver, BC, Canada
Correspondence to: Honglin Luo, MD, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Heart+Lung Research Institute, St. Paul's Hospital, Department of Pathology & Laboratory Medicine, University of British Columbia, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6, TEL: (604) 682-2344 ext. 62847 FAX : (604) 806-8351, E-mail: hluo{at}mrl.ubc.ca
The primary intracellular protein degradation systems, including the ubiquitin-proteasome and the lysosome pathways, have been emerging as central regulators of viral infectivity, inflammation, and viral pathogenicity. Viral myocarditis is an inflammatory disease of the myocardium caused by virus infection in the heart. The disease progression of viral myocarditis occurs in three distinct stages: acute viral infection, immune cell infiltration, and cardiac remodeling. Growing evidence suggests a crucial role for host proteolytic machineries in the regulation of the pathogenesis and progression of viral myocarditis in all three stages. Cardiotropic viruses evolve different strategies to subvert host protein degradation systems to achieve successful viral replication. In addition, these proteolytic systems play important roles in the activation of innate and adaptive immune responses during viral infection. Recent evidence also suggests a key role for the ubiquitin-proteasome and lysosome systems as the primary effectors of protein quality control in the regulation of cardiac remodeling. This review summarizes the recent advances in understanding the direct interaction between cardiotropic viruses and host proteolytic systems, with an emphasis on coxsackievirus B3, one of the primary etiological agents causing viral myocarditis, and highlights possible roles of the host degradation systems in the pathogenesis of viral myocarditis and its progression to dilated cardiomyopathy.
KEYWORDS Viral myocarditis; dilated cardiomyopathy; coxsackievirus; proteasome; immunoproteasome; autophagy; autophagosome
Time for primary review: 25 Days